{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:17:52Z","timestamp":1792045072768,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"DOI":"10.1038\/emm.2015.100","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T09:26:29Z","timestamp":1453454789000},"page":"e205-e205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"48","author":[{"given":"Young C","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Y","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun J","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung H","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang R","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yoon","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung K","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"BFemm2015100_CR1","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM . Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 2006; 116: 1744\u20131754.","journal-title":"J Clin Invest"},{"key":"BFemm2015100_CR2","first-page":"13","volume":"119","author":"SH Appel","year":"2009","unstructured":"Appel SH . CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. J Clin Invest 2009; 119: 13\u201315.","journal-title":"J Clin Invest"},{"key":"BFemm2015100_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS . Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57\u201369.","journal-title":"Nat Rev Neurosci"},{"key":"BFemm2015100_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","volume":"43","author":"YC Chung","year":"2010","unstructured":"Chung YC, Ko HW, Bok E, Park ES, Huh SH, Nam JH et al. The role of neuroinflammation on the pathogenesis of Parkinson\u2019s disease. BMB Rep 2010; 43: 225\u2013232.","journal-title":"BMB Rep"},{"key":"BFemm2015100_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang O . Role of oxidative stress in Parkinson\u2019s disease. Exp Neurobiol 2013; 22: 11\u201317.","journal-title":"Exp Neurobiol"},{"key":"BFemm2015100_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","volume":"1788","author":"N Weiss","year":"2009","unstructured":"Weiss N, Miller F, Cazaubon S, Couraud PO . The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 2009; 1788: 842\u2013857.","journal-title":"Biochim Biophys Acta"},{"key":"BFemm2015100_CR7","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.1523\/JNEUROSCI.0970-05.2005","volume":"25","author":"DK Choi","year":"2005","unstructured":"Choi DK, Pennathur S, Perier C, Tieu K, Teismann P, Wu DC et al. Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice. J Neurosci 2005; 25: 6594\u20136600.","journal-title":"J Neurosci"},{"key":"BFemm2015100_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","volume":"185","author":"YC Chung","year":"2010","unstructured":"Chung YC, Kim SR, Jin BK . Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson\u2019s disease. J Immunol 2010; 185: 1230\u20131237.","journal-title":"J Immunol"},{"key":"BFemm2015100_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4049\/jimmunol.1100009","volume":"187","author":"SH Huh","year":"2011","unstructured":"Huh SH, Chung YC, Piao Y, Jin MY, Son HJ, Yoon NS et al. Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson\u2019s disease. J Immunol 2011; 187: 960\u2013969.","journal-title":"J Immunol"},{"key":"BFemm2015100_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999; 5: 1403\u20131409.","journal-title":"Nat Med"},{"key":"BFemm2015100_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 1994; 180: 147\u2013150.","journal-title":"Neurosci Lett"},{"key":"BFemm2015100_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-211-73574-9_14","volume":"72","author":"T Nagatsu","year":"2007","unstructured":"Nagatsu T, Sawada M . Biochemistry of postmortem brains in Parkinson\u2019s disease: historical overview and future prospects. J Neural Transm Suppl 2007; 72: 113\u2013120.","journal-title":"J Neural Transm Suppl"},{"key":"BFemm2015100_CR13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002; 22: 1763\u20131771.","journal-title":"J Neurosci"},{"key":"BFemm2015100_CR14","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 2009; 119: 182\u2013192.","journal-title":"J Clin Invest"},{"key":"BFemm2015100_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2014.05.007","volume":"1571","author":"Y Kawamoto","year":"2014","unstructured":"Kawamoto Y, Ito H, Ayaki T, Takahashi R . Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies. Brain Res 2014; 1571: 39\u201348.","journal-title":"Brain Res"},{"key":"BFemm2015100_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V Di Marzo","year":"1994","unstructured":"Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994; 372: 686\u2013691.","journal-title":"Nature"},{"key":"BFemm2015100_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","volume":"28","author":"J Fernandez-Ruiz","year":"2007","unstructured":"Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M . Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 2007; 28: 39\u201345.","journal-title":"Trends Pharmacol Sci"},{"key":"BFemm2015100_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"JP Gong","year":"2006","unstructured":"Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006; 1071: 10\u201323.","journal-title":"Brain Res"},{"key":"BFemm2015100_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000100778","volume":"54","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES . Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006; 54: 231\u2013246.","journal-title":"Neuropsychobiology"},{"key":"BFemm2015100_CR20","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","volume":"23","author":"L Walter","year":"2003","unstructured":"Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G et al. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 2003; 23: 1398\u20131405.","journal-title":"J Neurosci"},{"key":"BFemm2015100_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/glia.10177","volume":"41","author":"F Facchinetti","year":"2003","unstructured":"Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A . Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia 2003; 41: 161\u2013168.","journal-title":"Glia"},{"key":"BFemm2015100_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","volume":"79","author":"AM Martin-Moreno","year":"2011","unstructured":"Martin-Moreno AM, Reigada D, Ramirez BG, Mechoulam R, Innamorato N, Cuadrado A et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol 2011; 79: 964\u2013973.","journal-title":"Mol Pharmacol"},{"key":"BFemm2015100_CR23","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"BG Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML . Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 2005; 25: 1904\u20131913.","journal-title":"J Neurosci"},{"key":"BFemm2015100_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/glia.20229","volume":"52","author":"S Ortega-Gutierrez","year":"2005","unstructured":"Ortega-Gutierrez S, Molina-Holgado E, Guaza C . Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia 2005; 52: 163\u2013168.","journal-title":"Glia"},{"key":"BFemm2015100_CR25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1248\/bpb.34.1090","volume":"34","author":"T Tanikawa","year":"2011","unstructured":"Tanikawa T, Kurohane K, Imai Y . Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis. Biol Pharm Bull 2011; 34: 1090\u20131093.","journal-title":"Biol Pharm Bull"},{"key":"BFemm2015100_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuroscience.2012.01.008","volume":"207","author":"D Fernandez-Lopez","year":"2012","unstructured":"Fernandez-Lopez D, Faustino J, Derugin N, Wendland M, Lizasoain I, Moro MA et al. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke. Neuroscience 2012; 207: 307\u2013315.","journal-title":"Neuroscience"},{"key":"BFemm2015100_CR27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1096\/fj.09-141275","volume":"24","author":"S Murikinati","year":"2010","unstructured":"Murikinati S, Juttler E, Keinert T, Ridder DA, Muhammad S, Waibler Z et al. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 2010; 24: 788\u2013798.","journal-title":"FASEB J"},{"key":"BFemm2015100_CR28","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jnr.23114","volume":"90","author":"PS Amenta","year":"2012","unstructured":"Amenta PS, Jallo JI, Tuma RF, Elliott MB . A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res 2012; 90: 2293\u20132305.","journal-title":"J Neurosci Res"},{"key":"BFemm2015100_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.20462","volume":"57","author":"A Pisani","year":"2005","unstructured":"Pisani A, Fezza F, Galati S, Battista N, Napolitano S, Finazzi-Agro A et al. High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson\u2019s disease patients. Ann Neurol 2005; 57: 777\u2013779.","journal-title":"Ann Neurol"},{"key":"BFemm2015100_CR30","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","volume":"29","author":"DA Price","year":"2009","unstructured":"Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E et al. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Eur J Neurosci 2009; 29: 2177\u20132186.","journal-title":"Eur J Neurosci"},{"key":"BFemm2015100_CR31","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.4049\/jimmunol.1102435","volume":"187","author":"YC Chung","year":"2011","unstructured":"Chung YC, Bok E, Huh SH, Park JY, Yoon SH, Kim SR et al. Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. J Immunol 2011; 187: 6508\u20136517.","journal-title":"J Immunol"},{"key":"BFemm2015100_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.neuropharm.2011.01.043","volume":"60","author":"YC Chung","year":"2011","unstructured":"Chung YC, Kim SR, Park JY, Chung ES, Park KW, Won SY et al. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 2011; 60: 963\u2013974.","journal-title":"Neuropharmacology"},{"key":"BFemm2015100_CR33","doi-asserted-by":"publisher","first-page":"370526","DOI":"10.1155\/2013\/370526","volume":"2013","author":"YC Chung","year":"2013","unstructured":"Chung YC, Kim YS, Bok E, Yune TY, Maeng S, Jin BK . MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease. Mediators Inflamm 2013; 2013: 370526.","journal-title":"Mediators Inflamm"},{"key":"BFemm2015100_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West MJ, Slomianka L, Gundersen HJ . Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482\u2013497.","journal-title":"Anat Rec"},{"key":"BFemm2015100_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 2005; 57: 176\u2013179.","journal-title":"Ann Neurol"},{"key":"BFemm2015100_CR36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1742-2094-9-188","volume":"9","author":"V Pisani","year":"2012","unstructured":"Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, Franciotta D et al. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. J Neuroinflammation 2012; 9: 188.","journal-title":"J Neuroinflammation"},{"key":"BFemm2015100_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","volume":"216","author":"YX Chao","year":"2009","unstructured":"Chao YX, He BP, Tay SS . Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease. J Neuroimmunol 2009; 216: 39\u201350.","journal-title":"J Neuroimmunol"},{"key":"BFemm2015100_CR38","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","volume":"107","author":"X Chen","year":"2008","unstructured":"Chen X, Lan X, Roche I, Liu R, Geiger JD . Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem 2008; 107: 1147\u20131157.","journal-title":"J Neurochem"},{"key":"BFemm2015100_CR39","doi-asserted-by":"publisher","first-page":"a009373","DOI":"10.1101\/cshperspect.a009373","volume":"2","author":"VH Perry","year":"2012","unstructured":"Perry VH . Innate inflammation in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2012; 2: a009373.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"BFemm2015100_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M et al. Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun 2009; 23: 55\u201363.","journal-title":"Brain Behav Immun"},{"key":"BFemm2015100_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","volume":"16","author":"M Shimoji","year":"2009","unstructured":"Shimoji M, Pagan F, Healton EB, Mocchetti I . CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease. Neurotox Res 2009; 16: 318\u2013328.","journal-title":"Neurotox Res"},{"key":"BFemm2015100_CR42","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/138161212799040574","volume":"18","author":"MA Panaro","year":"2012","unstructured":"Panaro MA, Cianciulli A . Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson\u2019s disease. Curr Pharm Des 2012; 18: 200\u2013208.","journal-title":"Curr Pharm Des"},{"key":"BFemm2015100_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S . Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 2009; 8: 382\u2013397.","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"BFemm2015100_CR44","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S . Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 2012; 18 (Suppl 1): S210\u2013S212.","journal-title":"Parkinsonism Relat Disord"},{"key":"BFemm2015100_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.expneurol.2012.08.020","volume":"238","author":"C Depboylu","year":"2012","unstructured":"Depboylu C, Stricker S, Ghobril JP, Oertel WH, Priller J, Hoglinger GU . Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp Neurol 2012; 238: 183\u2013191.","journal-title":"Exp Neurol"},{"key":"BFemm2015100_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1874609811306010007","volume":"6","author":"FL Episcopo","year":"2013","unstructured":"Episcopo FL, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B . Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration. Curr Aging Sci 2013; 6: 45\u201355.","journal-title":"Curr Aging Sci"},{"key":"BFemm2015100_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nurt.2010.07.001","volume":"7","author":"PM Rappold","year":"2010","unstructured":"Rappold PM, Tieu K . Astrocytes and therapeutics for Parkinson\u2019s disease. Neurotherapeutics 2010; 7: 413\u2013423.","journal-title":"Neurotherapeutics"},{"key":"BFemm2015100_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","volume":"14","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK et al. The role of glial cells in Parkinson\u2019s disease. Curr Opin Neurol 2001; 14: 483\u2013489.","journal-title":"Curr Opin Neurol"},{"key":"BFemm2015100_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10571-007-9241-2","volume":"28","author":"C Oki","year":"2008","unstructured":"Oki C, Watanabe Y, Yokoyama H, Shimoda T, Kato H, Araki T . Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice. Cell Mol Neurobiol 2008; 28: 417\u2013430.","journal-title":"Cell Mol Neurobiol"},{"key":"BFemm2015100_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1471-4159.2002.01131.x","volume":"83","author":"LM Bolin","year":"2002","unstructured":"Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Di Monte D . Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem 2002; 83: 167\u2013175.","journal-title":"J Neurochem"},{"key":"BFemm2015100_CR51","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V92.9.3007","volume":"92","author":"MB Hampton","year":"1998","unstructured":"Hampton MB, Kettle AJ, Winterbourn CC . Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007\u20133017.","journal-title":"Blood"},{"key":"BFemm2015100_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.abb.2010.04.008","volume":"500","author":"J Arnhold","year":"2010","unstructured":"Arnhold J, Flemmig J . Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 2010; 500: 92\u2013106.","journal-title":"Arch Biochem Biophys"},{"key":"BFemm2015100_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM . TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis 2007; 26: 36\u201346.","journal-title":"Neurobiol Dis"},{"key":"BFemm2015100_CR54","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","volume":"101","author":"I Rite","year":"2007","unstructured":"Rite I, Machado A, Cano J, Venero JL . Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J Neurochem 2007; 101: 1567\u20131582.","journal-title":"J Neurochem"},{"key":"BFemm2015100_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai BS, Monahan AJ, Carvey PM, Hendey B . Blood-brain barrier pathology in Alzheimer's and Parkinson\u2019s disease: implications for drug therapy. Cell Transplant 2007; 16: 285\u2013299.","journal-title":"Cell Transplant"}],"container-title":["Experimental & Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/emm2015100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2015100","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm2015100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:44:07Z","timestamp":1718318647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2015100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"alternative-id":["BFemm2015100"],"URL":"https:\/\/doi.org\/10.1038\/emm.2015.100","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]},"assertion":[{"value":"23 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}